aristolochic acid nephropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: In year 1998-2015,The patients undergoing renal replacement therapy in out hospital because of end-stage aristolochic acid nephropathy who had occured upper urinary tract tumors.;Inclusion criteria: In year 1998-2015,The patients undergoing renal replacement therapy in out hospital because of end-stage aristolochic acid nephropathy who had occured upper urinary tract tumors.;Inclusion criteria: In year 1998-2015,The patients undergoing renal replacement therapy in out hospital because of end-stage aristolochic acid nephropathy who had occured upper urinary tract tumors.;Inclusion criteria: In year 1998-2015,The patients undergoing renal replacement therapy in out hospital because of end-stage aristolochic acid nephropathy who had occured upper urinary tract tumors.;Inclusion criteria: In year 1998-2015,The patients undergoing renal replacement therapy in out hospital because of end-stage aristolochic acid nephropathy who had occured upper urinary tract tumors.
Exclusion criteria
Exclusion criteria: patient who has a tumor elsewhere;Exclusion criteria: patient who has a tumor elsewhere;Exclusion criteria: patient who has a tumor elsewhere;Exclusion criteria: patient who has a tumor elsewhere;Exclusion criteria: patient who has a tumor elsewhere
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Age at diagnosis as AAN;Age at when begin renal replacement; | — |
Countries
China
Contacts
Department of Transplantation, the First Affiliated Hospital of Wenzhou Medical University;Department of Transplantation, the First Affiliated Hospital of Wenzhou Medical University;Department of Transplantation, the First Affiliated Hospital of Wenzhou Medical University;Department of Transplantation, the First Affiliated Hospital of Wenzhou Medical University;Department of Transplantation, the First Affiliated Hospital of Wenzhou Medical University